Stereotaxis
Stereotaxis develops robotic cardiology instrument navigation systems that enhances the treatment of arrhythmias and coronary diseases. Learn more
Launch date
Employees
Market cap
€169m
Enterprise valuation
€166m (Public information from Sep 2024)
Share price
$2 STXS
Saint-Louis Département de Saint-Louis (HQ)
Authorizing premium user...